Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

S. aureus infections in hospitalized children with hematological, hepatological or kidney diseases over a 16-year period at a tertiary care hospital in Sweden: a retrospective observational study.

Italian journal of pediatrics·2026
Same author

Pneumococcal membrane particles promote serotype-independent cellular and humoral immunity and protect against pneumococcal colonization.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

Identification of immunostimulatory antigens in Group A <i><i>Streptococcus</i></i>-derived vesicles.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

Closing the Stable Door on Strangles: Serological Responses of Vaccinated Horses on a Farm Following the Arrival of a New Horse.

Animals : an open access journal from MDPI·2025
Same author

Reining in strangles: Absence of disease in horses vaccinated with a DIVA-compatible recombinant fusion protein vaccine, Strangvac, following natural exposure to Streptococcus equi subspecies equi.

Equine veterinary journal·2025
Same author

Neutralisation of the Immunoglobulin-Cleaving Activity of <i>Streptococcus equi</i> Subspecies <i>equi</i> IdeE by Blood Sera from Ponies Vaccinated with a Multicomponent Protein Vaccine.

Vaccines·2025

Related Experiment Video

Updated: May 10, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

The pneumococcus: epidemiology, microbiology, and pathogenesis.

Birgitta Henriques-Normark1, Elaine I Tuomanen

  • 1Department of Microbiology, Tumor, and Cell Biology, Karolinska Institutet, SE-171 77 Stockholm, Sweden.

Cold Spring Harbor Perspectives in Medicine
|July 3, 2013
PubMed
Summary

Streptococcus pneumoniae, a major pathogen, causes significant global disease. Understanding its pathogenesis and host immune responses is crucial for developing effective treatments and vaccines.

More Related Videos

Characterization of Inflammatory Responses During Intranasal Colonization with Streptococcus pneumoniae
09:12

Characterization of Inflammatory Responses During Intranasal Colonization with Streptococcus pneumoniae

Published on: January 17, 2014

Constructing Mutants in Serotype 1 Streptococcus pneumoniae strain 519/43
06:06

Constructing Mutants in Serotype 1 Streptococcus pneumoniae strain 519/43

Published on: September 11, 2020

Related Experiment Videos

Last Updated: May 10, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

Characterization of Inflammatory Responses During Intranasal Colonization with Streptococcus pneumoniae
09:12

Characterization of Inflammatory Responses During Intranasal Colonization with Streptococcus pneumoniae

Published on: January 17, 2014

Constructing Mutants in Serotype 1 Streptococcus pneumoniae strain 519/43
06:06

Constructing Mutants in Serotype 1 Streptococcus pneumoniae strain 519/43

Published on: September 11, 2020

Area of Science:

  • Microbiology
  • Immunology
  • Pathogenesis

Background:

  • Streptococcus pneumoniae is a leading Gram-positive bacterial pathogen responsible for substantial global disease burden.
  • Over a century of research has elucidated key aspects of pneumococcal physiology, disease mechanisms, and host immunity.
  • Pneumococcal infections pose a significant challenge due to evolving antibiotic resistance and potent inflammatory responses.

Purpose of the Study:

  • To review the fundamental aspects of Streptococcus pneumoniae pathogenesis.
  • To discuss the host immune responses elicited by pneumococcal infections.
  • To highlight the impact of pneumococcal diseases and control strategies.

Main Methods:

  • Literature review of historical and recent studies on Streptococcus pneumoniae.
  • Analysis of research on pneumococcal virulence factors and host-pathogen interactions.
  • Synthesis of information on vaccine development and antibiotic resistance.

Main Results:

  • Pneumococcus serves as a model organism for Gram-positive bacterial pathogenesis.
  • The inflammatory response to pneumococci effectively clears infection but can also cause host tissue damage.
  • Vaccine strategies and antibiotic stewardship are critical for managing pneumococcal diseases.

Conclusions:

  • Streptococcus pneumoniae remains a critical focus in infectious disease research.
  • Understanding the complex interplay between pneumococcus and the host immune system is vital for public health.
  • Continued research is necessary to combat the evolving threat of pneumococcal infections.